Top compounds associated with response to CRK


Feature Type Standardized
Nominal ANOVA
mRNA Roscovitine FIMM pan-cancer AAC 0.67 0.003
mRNA Bleomycin GDSC1000 pan-cancer AAC 0.12 0.004
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.13 0.004
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.15 0.004
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.004
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.12 0.004
mRNA TW 37 GDSC1000 pan-cancer AAC 0.11 0.005
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.006
mRNA AMG-706 GDSC1000 pan-cancer AAC 0.12 0.006
mRNA Vinorelbine GDSC1000 pan-cancer AAC 0.11 0.006
Download CSV